Canadian Bioceutical Subsidiary Signs Collaboration Agreement With a Leading Israeli Medical Cannabis Research Company

Following on its recent announcement of plans to enter the medical marijuana sector with a large development in Owen Sound, Ontario, The Canadian Bioceutical Corporation’s (TSXV:BCC) wholly-owned subsidiary BioCannabis Products Ltd., is pleased to announce that it has entered into an agreement with the Tel Aviv-based Cannabliss Ltd. 

The terms of the Agreement call for the two companies to cooperate and collaborate in the conception, research, development and production of cannabis-related medicinal products and technologies with the eventual goal of consummating licensing and distribution agreements for the Canadian medical marijuana market.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s